These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8514444)
1. In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index. Merlo GR; Bernardi A; Diella F; Venesio T; Cappa AP; Callahan R; Liscia DS Int J Cancer; 1993 Jun; 54(4):531-5. PubMed ID: 8514444 [TBL] [Abstract][Full Text] [Related]
2. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Thorlacius S; Börresen AL; Eyfjörd JE Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635 [TBL] [Abstract][Full Text] [Related]
3. p53 mutations occur in aggressive breast cancer. Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667 [TBL] [Abstract][Full Text] [Related]
4. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families. Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151 [TBL] [Abstract][Full Text] [Related]
5. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005 [TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781 [TBL] [Abstract][Full Text] [Related]
7. p53 mutations and histological type of invasive breast carcinoma. Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644 [TBL] [Abstract][Full Text] [Related]
8. p53 mutations and overexpression in locally advanced breast cancers. Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984 [TBL] [Abstract][Full Text] [Related]
9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
10. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas. Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152 [TBL] [Abstract][Full Text] [Related]
12. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay. Duddy PM; Hanby AM; Barnes DM; Camplejohn RS J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518 [TBL] [Abstract][Full Text] [Related]
13. A novel 23-bp deletion in exon 5 of the p53 tumor suppressor gene. Patrinos GP; Garinis G; Kounelis S; Kouri E; Menounos P J Mol Med (Berl); 1999 Sep; 77(9):686-9. PubMed ID: 10569206 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 gene in human functional adrenal neoplasms. Lin SR; Lee YJ; Tsai JH J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638 [TBL] [Abstract][Full Text] [Related]
15. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188 [TBL] [Abstract][Full Text] [Related]
16. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer]. Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382 [TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on exons 5-8 of p53 gene mutation in laryngeal squamous cell carcinoma]. Zhang X; Liu S; Zhou G; Liang C; Lin D; Qiao X Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):295-7. PubMed ID: 12545812 [TBL] [Abstract][Full Text] [Related]
18. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer. Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068 [TBL] [Abstract][Full Text] [Related]
19. Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer. Lee LN; Shew JY; Sheu JC; Lee YC; Lee WC; Fang MT; Chang HF; Yu CJ; Yang PC; Luh KT Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1667-71. PubMed ID: 7952630 [TBL] [Abstract][Full Text] [Related]
20. Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene. Sturm I; Papadopoulos S; Hillebrand T; Benter T; Lück HJ; Wolff G; Dörken B; Daniel PT Int J Cancer; 2000 Aug; 87(4):517-21. PubMed ID: 10918191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]